COVID-19-Associated Mucormycosis: Identifying Mortality Predictors in a Retrospective Cohort Study - Top-Institutions - MDSpire

COVID-19-Associated Mucormycosis: Identifying Mortality Predictors in a Retrospective Cohort Study

  • By

  • Zahra Ghavami

  • Mahboubeh Haddad

  • Fereshte Sheybani

  • Matin Shirazinia

  • Maliheh Dadgar Moghadam

  • November 3, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Medical Mycology
    • Immunology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Infectious Diseases
    • Hematology
    • Endocrinology

  • #3

    All India Institute of Medical Sciences (AIIMS)
    All India Institute of Medical Sciences (AIIMS)

    New Delhi, Delhi

    Key Differentiators

    • Infectious Diseases
    • Medical Mycology
    • Critical Care

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Pharmacology

Original Source(s)

COVID-19-Associated Mucormycosis: Identifying Mortality Predictors in a Retrospective Cohort Study

  • by Zahra Ghavami, Mahboubeh Haddad, Fereshte Sheybani, Matin Shirazinia, Maliheh Dadgar Moghadam

  • November 3, 2025

Related Content

Assessing the association of physical distancing to avoid COVID-19 with health-related quality of life in immunocompromised adolescents: results from the cross-sectional observational EAGLE study

Antibiotics May Not Help Mild COVID

A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.

Raman Spectroscopy Moves to the Front Line of Pandemic Preparedness

Comprehensive review highlights label-free viral detection – and the hurdles to real-world deployment

  • May 7, 2026

  • 2 min